Cargando…

Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease

Chagas disease, a neglected tropical disease, is now considered a worldwide health concern as a result of migratory movements from Central and South America to other regions that were considered free of the disease, and where the epidemiological risk is limited to transplacental transmission or bloo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lozano, Noelia, Samblas, Mercedes Gomez, Calabuig, Eva, Giménez Martí, María José, Gómez Ruiz, Maria Dolores, Arce, José Miguel Sahuquillo, Sequera-Arquelladas, Sergio, Moreno, José Miguel Molina, Trelis, M., Osuna, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10490946/
https://www.ncbi.nlm.nih.gov/pubmed/37682970
http://dx.doi.org/10.1371/journal.pone.0282814
_version_ 1785103959297359872
author Lozano, Noelia
Samblas, Mercedes Gomez
Calabuig, Eva
Giménez Martí, María José
Gómez Ruiz, Maria Dolores
Arce, José Miguel Sahuquillo
Sequera-Arquelladas, Sergio
Moreno, José Miguel Molina
Trelis, M.
Osuna, Antonio
author_facet Lozano, Noelia
Samblas, Mercedes Gomez
Calabuig, Eva
Giménez Martí, María José
Gómez Ruiz, Maria Dolores
Arce, José Miguel Sahuquillo
Sequera-Arquelladas, Sergio
Moreno, José Miguel Molina
Trelis, M.
Osuna, Antonio
author_sort Lozano, Noelia
collection PubMed
description Chagas disease, a neglected tropical disease, is now considered a worldwide health concern as a result of migratory movements from Central and South America to other regions that were considered free of the disease, and where the epidemiological risk is limited to transplacental transmission or blood or organ donations from infected persons. Parasite detection in chronically ill patients is restricted to serological tests that only determine infection by previous infection and not the presence of the parasite, especially in patients undergoing treatment evaluation or in newborns. We have evaluated the use of nucleic acids from both circulating exovesicles and cell-free DNA (cfDNA) from 50 samples twice randomly selected from a total of 448 serum samples from immunologically diagnosed patients in whom the presence of the parasite was confirmed by nested PCR on amplicons resulting from amplification with kinetoplastid DNA-specific primers 121F-122R. Six samples were randomly selected to quantify the limit of detection by qPCR in serum exovesicles. When the nucleic acids thus purified were assayed as a template and amplified with kinetoplastid DNA and nuclear satellite DNA primers, a 100% positivity rate was obtained for all positive samples assayed with kDNA-specific primers and 96% when SAT primers were used. However, isolation of cfDNA for Trypanosoma cruzi and amplification with SAT also showed 100% positivity. The results demonstrate that serum exovesicles contain DNA of mitochondrial and nuclear origin, which can be considered a mixed population of exovesicles of parasitic origin. The results obtained with serum samples prove that both cfDNA and Exovesicle DNA can be used to confirm parasitaemia in chronically ill patients or in samples where it is necessary to demonstrate the active presence of the parasite. The results confirm for the first time the existence of exovesicles of mitochondrial origin of the parasite in the serum of those affected by Chagas disease.
format Online
Article
Text
id pubmed-10490946
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-104909462023-09-09 Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease Lozano, Noelia Samblas, Mercedes Gomez Calabuig, Eva Giménez Martí, María José Gómez Ruiz, Maria Dolores Arce, José Miguel Sahuquillo Sequera-Arquelladas, Sergio Moreno, José Miguel Molina Trelis, M. Osuna, Antonio PLoS One Research Article Chagas disease, a neglected tropical disease, is now considered a worldwide health concern as a result of migratory movements from Central and South America to other regions that were considered free of the disease, and where the epidemiological risk is limited to transplacental transmission or blood or organ donations from infected persons. Parasite detection in chronically ill patients is restricted to serological tests that only determine infection by previous infection and not the presence of the parasite, especially in patients undergoing treatment evaluation or in newborns. We have evaluated the use of nucleic acids from both circulating exovesicles and cell-free DNA (cfDNA) from 50 samples twice randomly selected from a total of 448 serum samples from immunologically diagnosed patients in whom the presence of the parasite was confirmed by nested PCR on amplicons resulting from amplification with kinetoplastid DNA-specific primers 121F-122R. Six samples were randomly selected to quantify the limit of detection by qPCR in serum exovesicles. When the nucleic acids thus purified were assayed as a template and amplified with kinetoplastid DNA and nuclear satellite DNA primers, a 100% positivity rate was obtained for all positive samples assayed with kDNA-specific primers and 96% when SAT primers were used. However, isolation of cfDNA for Trypanosoma cruzi and amplification with SAT also showed 100% positivity. The results demonstrate that serum exovesicles contain DNA of mitochondrial and nuclear origin, which can be considered a mixed population of exovesicles of parasitic origin. The results obtained with serum samples prove that both cfDNA and Exovesicle DNA can be used to confirm parasitaemia in chronically ill patients or in samples where it is necessary to demonstrate the active presence of the parasite. The results confirm for the first time the existence of exovesicles of mitochondrial origin of the parasite in the serum of those affected by Chagas disease. Public Library of Science 2023-09-08 /pmc/articles/PMC10490946/ /pubmed/37682970 http://dx.doi.org/10.1371/journal.pone.0282814 Text en © 2023 Lozano et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Lozano, Noelia
Samblas, Mercedes Gomez
Calabuig, Eva
Giménez Martí, María José
Gómez Ruiz, Maria Dolores
Arce, José Miguel Sahuquillo
Sequera-Arquelladas, Sergio
Moreno, José Miguel Molina
Trelis, M.
Osuna, Antonio
Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease
title Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease
title_full Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease
title_fullStr Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease
title_full_unstemmed Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease
title_short Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease
title_sort use of sera cell free dna (cfdna) and exovesicle-dna for the molecular diagnosis of chronic chagas disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10490946/
https://www.ncbi.nlm.nih.gov/pubmed/37682970
http://dx.doi.org/10.1371/journal.pone.0282814
work_keys_str_mv AT lozanonoelia useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease
AT samblasmercedesgomez useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease
AT calabuigeva useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease
AT gimenezmartimariajose useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease
AT gomezruizmariadolores useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease
AT arcejosemiguelsahuquillo useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease
AT sequeraarquelladassergio useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease
AT morenojosemiguelmolina useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease
AT trelism useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease
AT osunaantonio useofseracellfreednacfdnaandexovesiclednaforthemoleculardiagnosisofchronicchagasdisease